Spiriva vs Trelegy
What to choose Spiriva or Trelegy
Spiriva is inhaler of type Control while Trelegy is of Control type. Spiriva and Trelegy are both brand inhalers. Spiriva is manufactured by pharmaceutical company Boehringer Ingelheim, while Trelegy is manufactured by GSK. The main substance of Spiriva is Tiotropium. The available dosage for Spiriva is 9 mcg. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg.
The current price for Spiriva is roughly $423 while average price for Trelegy is around $619.92, said Murphy Smith, an Adjunct Professor at the Louisiana State University and a Patient Representative at a clinic that uses Spiriva and Trelegy.
Spiriva and Trelegy Comparison
| Spiriva | Trelegy | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Boehringer Ingelheim | GSK |
| Substance: | Tiotropium | Fluticasone + Vilanterol |
| Dosage: | 9 mcg | 100 mcg / 25 mcg |
| Avg Price: | $423 | $619.92 |